The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival

Journal of Urology

Volumn 182, Issue 5, 2009, Pages 2144-2149

  Zubac, Dragomir P ^a   Bostad, Leif ^b   Kihl, Björn ^d   Seidal, Tomas ^d   Wentzel Larsen, Tore ^c   Haukaas, Svein A ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d CENTRAL HOSPITAL   (Sweden)

Author keywords

angiogenesis modulating agents; carcinoma; prognosis; renal cell; thrombospondin 1; tumor suppressor protein p53

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; KI 67 ANTIGEN; PARAFFIN; PROTEIN P53; THROMBOSPONDIN 1;

ANGIOGENESIS; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MICROVASCULATURE; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; TUMOR GROWTH; TUMOR VOLUME; BIOSYNTHESIS; CHEMISTRY; KIDNEY TUMOR; METABOLISM; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SURVIVAL RATE;

BIOLOGICAL MARKERS; CARCINOMA, RENAL CELL; CELL PROLIFERATION; HUMANS; KIDNEY NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE; THROMBOSPONDIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70350438226     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.015     Document Type: Article

References (25)

1. Gordon M.S. Novel antiangiogenic therapies for renal cell cancer. Clin Cancer Res 10 (2004) 6377
2. Fox S.B., Gasparini G., and Harris A.L. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drags. Lancet Oncol 2 (2001) 278
3. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Moll Med 6 (2002) 1
4. Ren B., Yee K.O., Lawler J., et al. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 1765 (2006) 178
5. Kazerounian S., Yee O., and Lawler J. Thrombospondins in cancer. Cell Mol Life Sci 65 (2008) 700
6. Arai E., Ushijima S., Tsuda H., et al. Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome. Clin Cancer Res 14 (2008) 5531
7. Ljungberg B., Bozoky B., Kovacs G., et al. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma. Scand J Urol Nephrol 35 (2001) 15
8. Kramer B.A., Gao X., Davis M., et al. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma. J Am Coll Surg 201 (2005) 565
9. Kankuri M., Söderström K.O., Pelliniemi T.T., et al. The association of immunoreactive p53 and Ki-67 with T-stage, grade, occurrence of metastases and survival in renal cell carcinoma. Anticancer Res 26 (2006) 3825
10. Zubac D.P., Bostad L., Gestblom C., et al. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy. Scand J Urol Nephrol 41 (2007) 191
11. th ed. (2002), Springer-Verlag, New York 323
12. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655
13. Grossfeld G.D., Shi S.R., Ginsberg D.A., et al. Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 44 (1996) 761
14. Weidner N., Semple J.P., Welch W.R., et al. Tumor angiogenesis and metastasis- correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1
15. Miyata Y., Koga S., Takehara K., et al. Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and angiogenesis. Clin Cancer Res 9 (2003) 1734
16. Veliceasa D., Ivanovic M., Hoepfner F.T., et al. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma. FEBS J 274 (2007) 6365
17. Baltici S., Orhan D., Gogus C., et al. Thrombospondin-1, vascular endothelial growth factor expression and microvascular density in renal cell carcinoma and their relationship with multifocality. Eur Urol 44 (2003) 76
18. Levine A.J., Momand J., and Finlay C.A. The p53 tumour suppressor gene. Nature 351 (1991) 453
19. Uhlman D.L., Nguyen P.L., Manivel J.C., et al. Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 86 (1994) 1470
20. Zigeuner R., Ratschek M., Rehak P., et al. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Urology 63 (2004) 651
21. Haitel A., Wiener H.G., Baethge U., et al. mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters. Clin Cancer Res 6 (2000) 1840
22. Pepe S., Ruggiero A., D'Acquisto M., et al. Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal cell carcinomas. Cancer 89 (2000) 1065
23. Chemeris G., Loktinov A., Rempel A., et al. Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Virchows Arch 426 (1995) 563
24. Ebbinghaus S., Hussain M., Tannir N., et al. Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma. Clin Cancer Res 13 (2007) 6689
25. Miyanaga K., Kato Y., Nakamura T., et al. Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Res 22 (2002) 3941